Abstract:Parkinson's disease (PD) is a chronic progressive neurodegenerative disorder symptomatically characterized by resting tremor, rigidity, bradykinesia and gait impairment. These motor deficits suffered by PD patients primarily result from selective dysfunction or loss of dopaminergic neurons of the substantia nigra pars compacta (SNpc). Most of the existing therapies for PD are based on the replacement of dopamine, which is symptomatically effective in the early stage but becomes increasingly less effective and is accompanied by serious side effects in the advanced stages of the disease. Currently, there are no strategies to slow neuronal degeneration or prevent the progression of PD. Thus, the prospect of regenerating functional dopaminergic neurons is very attractive. Over the last few decades, significant progress has been made in the development of dopaminergic regenerative strategies for curing PD. The most promising approach seems to be cell-replacement therapy (CRT) using human embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs), which are unlimitedly available and have gained much success in preclinical trials. Despite the challenges, stem cell-based CRT will make significant steps toward the clinic in the coming decade. Alternatively, direct lineage reprogramming, especially in situ direct conversion of glia cells to induced neurons, which exhibits some advantages including no ethical concerns, no risk of neoplasia, and even no need for transplantation, has gained much attention recently. Evoking the endogenous regeneration ability of neural stem cells (NSCs) is an idyllic method of dopaminergic neuroregeneration which remains highly controversial. Here, we review many of these advances, highlighting areas and strategies that might be particularly suited to the development of regenerative approaches that restore dopaminergic function in PD. Key words: Parkinson's disease, dopaminergic neurons, embryonic stem cell, induced pluripotent stem cell, neural stem cell, direct lineage reprogramming, endogenous regeneration.

Stem Cell Therapy for the Treatment of Parkinson's Disease: What Promise Does it Hold?

Stem Cell Therapy for Parkinson's Disease

Cell Therapy for Parkinson's Disease

Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson’s Disease

Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.

Progress in dopaminergic cell-replacement and regenerative strategies for Parkinson's disease.

Stem Cells for the Treatment of Neurodegenerative Diseases

Cell therapy for Parkinson’s disease with induced pluripotent stem cells

Research progress of neural stem cells as a source of dopaminergic neurons for cell therapy in Parkinson's disease

Advancing Parkinson's disease treatment: cell replacement therapy with neurons derived from pluripotent stem cells

Stem Cell-Based Approaches in Parkinson’s Disease Research

Overcoming Methodological Challenges for Advancing Stem Cell Therapies in Parkinson's Disease

Pluripotent Stem Cell Therapies for Parkinson Disease: Present Challenges and Future Opportunities

Induced Pluripotent Stem Cells and Parkinson's Disease: Modelling and Treatment

Cells therapy for Parkinson’s disease—so close and so far away

Therapeutic application of stem cell technology toward the treatment of Parkinson's disease.

Current Developments in Cell Replacement Therapy for Parkinson's Disease

Advancements in Autologous Stem Cell Transplantation for Parkinson's Disease

A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future Prospects

Emerging regenerative medicine and tissue engineering strategies for Parkinson’s disease

Can Pluripotent/multipotent Stem Cells Reverse Parkinson’s Disease Progression?